Precision Therapeutics Income Statement
View: Annual
| Dec 06 | Dec 05 | Dec 04 | |
|---|---|---|---|
| Revenue | 0.8 | 1.9 | 1.5 |
| Cost of Goods Sold | 1.1 | 1.0 | 1.0 |
| Gross Profit | (0.2) | 0.9 | 0.6 |
| Gross Profit Margin | 0.0% | 49.1% | 36.5% |
| SG&A Expense | 9.1 | 5.7 | 6.3 |
| Depreciation & Amortization | -- | -- | -- |
| Operating Income | (9.3) | (4.8) | (5.7) |
| Operating Margin | -- | -- | -- |
| Nonoperating Income | 0.7 | 0.1 | 0.1 |
| Nonoperating Expenses | 0.0 | 0.1 | 0.1 |
| Income Before Taxes | (8.6) | (4.7) | (5.8) |
| Income Taxes | 0.0 | 0.0 | 0.0 |
| Net Income After Taxes | (8.6) | (4.7) | (5.8) |
| Continuing Operations | (8.6) | (4.7) | (5.8) |
| Discontinued Operations | 0.0 | 0.0 | 0.0 |
| Total Operations | (8.6) | (4.7) | (5.8) |
| Total Net Income | (8.6) | (4.7) | (5.8) |
| Net Profit Margin | -- | -- | -- |
| Diluted EPS from Total Net Income ($) | -- | -- | -- |
| Dividends per Share | -- | -- | -- |
